VanEck Pharmaceutical ETF
Not enough financial coverage to compute a composite score for PPH. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Companywww.vaneck.com/us/en/investments/pharmaceutical-etf-pph
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
- IPO
- 2000
- HQ
- New York, NY, US
Price Chart
Valuation
- Market Cap
- $605.86M
- Div Yield
- 2.10%
Performance & Tape
- 52W High
- $112.58
- 52W Low
- $81.74
- 50D MA
- $102.38
- 200D MA
- $99.04
- Beta
- 0.46
- Avg Volume
- 288.67K
Get TickerSpark's AI analysis on PPH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PPH Coverage
We haven't published any research on PPH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PPH Report →